VEGFA and hereditary angioedema: Subgroup analysis further demonstrated that VEGF levels were markedly elevated in HAE patients with more frequent attacks, poorer disease control and greater disease severity compared to those with less frequent and severe manifestations, suggesting the potential role of circulating VEGF as a biomarker for disease monitoring.